Chronic paronychia associated with fluconazole use in two pediatric patients with coccidioidomycosis
- PMID: 39045033
- PMCID: PMC11265586
- DOI: 10.1016/j.idcr.2024.e02026
Chronic paronychia associated with fluconazole use in two pediatric patients with coccidioidomycosis
Abstract
Azoles are frequently used to treat systemic mycoses but have been associated with a number of adverse effects of the skin and skin appendages. Herein we describe two cases of chronic paronychia in pediatric patients receiving fluconazole for coccidioidomycosis. Their clinical characteristics are described, and the literature reviewed.
Keywords: Adverse drug effect; Chronic paronychia; Coccidioidomycosis; Fluconazole.
© 2024 Published by Elsevier Ltd.
Conflict of interest statement
Nathan B. Price, MD: Consulted for DSM-Firmenich; no relevant conflict of interest to disclose. Emily S. Cormack, PharmD: nothing to disclose. Kathryn R. Matthias, PharmD: nothing to disclose. Kareem W. Shehab, MD: nothing to disclose.
References
-
- Wollina U. Systemic drug-induced chronic paronychia and periungual pyogenic granuloma. Indian Dermatol Online J. 2018;9(5):293–298. https://doi.org/10.4103%2Fidoj.IDOJ_133_18. - PMC - PubMed
-
- Davies-Strickleton H., Cook J., Hannam S., et al. Assessment of the nail penetration of antifungal agents. PLoS One. 2020;15(2) https://doi.org/10.1371%2Fjournal.pone.0229414. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
